サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1531982

高免疫グロブリンの世界市場レポート 2024年

Hyperimmune Globulins Global Market Report 2024
出版日: | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.72円
高免疫グロブリンの世界市場レポート 2024年
出版日: 2024年08月12日
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
ご注意事項 :
本レポートの納品は、最新情報反映のため受注時に適宜更新しお届けいたします。
更新情報の反映作業にあたり納期もレポート毎に異なりますので、ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

高免疫グロブリン市場規模は、今後数年間で力強い成長が見込まれます。2028年にはCAGR7.7％で25億7,000万米ドルに成長します。予測期間の成長は、感染症の流行増加、高免疫グロブリン注射の利点に対する認識の高まり、免疫グロブリンの需要増加、α-1抗トリプシン欠乏症の症例増加、免疫不全の発生率上昇に起因すると予想されます。予測期間中に予想される主な動向には、技術の進歩と革新、研究開発への多額の投資、受動免疫治療に対する需要の増加、血漿由来治療の進歩、製造工程における技術強化などがあります。

高免疫グロブリン市場は、感染症の蔓延の増加により成長するとみられます。ウイルス、細菌、真菌、寄生虫などの病原体によって引き起こされるこれらの疾患は、抗菌薬耐性、気候変動、人口増加などの要因により増加傾向にあります。高免疫グロブリンは、特定の病原体を標的とする濃縮抗体を介して即時受動免疫を提供することにより、感染症との闘いに重要な役割を果たしています。これは、2021年から2022年にかけて米国の患者数が17％増加したB型慢性肝炎のようなケースに見られるように、疾患の予防や治療に役立ちます。したがって、感染症の増加は高免疫グロブリン市場に直接的な影響を与えています。

ヘルスケアの研究開発を推進する政府の取り組みは、今後数年間で高免疫グロブリン市場を押し上げる構えです。こうした取り組みは、革新的な医療ソリューションに対する需要の高まりや、新たな健康問題に立ち向かう必要性から活発化しています。これらは、特に特定の感染症に効果的に対処するために、高免疫グロブリンの開発とアクセシビリティを促進する上で重要な役割を果たしています。例えば、英国政府は2022年、ビジネス・エネルギー・産業戦略（BEIS）および保健社会ケア省（DHSC）を通じて、2億6,000万ポンド（米国2億7,065万米ドル）を医療研究と製造の強化に割り当てた。この資金は、NHS主導の健康研究、診断と治療のためのプライバシーを保護する新しいプラットフォーム、臨床研究サービスを支援するもので、英国におけるライフサイエンス製造業を強化するための6,000万ポンド（6,360万米国ドル）も含まれています。したがって、ヘルスケア研究開発に対する政府の注目の高まりは、高免疫グロブリン市場の主要な促進要因です。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界の市場規模と成長

  • 世界の高免疫グロブリン市場：促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の高免疫グロブリン市場の実績：規模と成長、2018年～2023年
  • 世界の高免疫グロブリン市場の予測：規模と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

  • 世界の高免疫グロブリン市場：タイプ別、実績と予測、2018年～2023年、2023年～2028年、2033年
  • B型肝炎高度免疫グロブリン
  • 狂犬病高度免疫グロブリン
  • 破傷風高度免疫グロブリン
  • サイトメガロウイルス（CMV）高免疫グロブリン
  • 水痘帯状疱疹ウイルス（VZV）高度免疫グロブリン
  • RSウイルス（RSV）高度免疫グロブリン
  • その他のタイプ
  • 世界の高免疫グロブリン市場：投与経路別、実績と予測、2018年～2023年、2023年～2028年、2033年
  • 筋肉内
  • 静脈内
  • 世界の高免疫グロブリン市場：用途別、実績と予測、2018年～2023年、2023年～2028年、2033年
  • 政府機関
  • 民間セクター
  • その他の用途

第7章 地域別・国別分析

  • 世界の高免疫グロブリン市場：地域別、実績と予測、2018年～2023年、2023年～2028年、2033年
  • 世界の高免疫グロブリン市場：国別、実績と予測、2018年～2023年、2023年～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 高免疫グロブリン市場：競合情勢
  • 高免疫グロブリン市場：企業プロファイル
    • F. Hoffmann-La Roche AG
    • Bayer AG
    • Takeda Pharmaceutical Company Limited
    • Baxter International Inc.
    • CSL Ltd.

第31章 その他の大手企業と革新的企業

  • Fresenius Kabi AG
  • Grifols SA
  • Octapharma AG
  • Shanghai RAAS Blood Products Co. Ltd.
  • Emergent BioSolutions Inc.
  • Kedrion Biopharma Inc.
  • LFB SA
  • Hualan Biological Engineering Inc.
  • FFF Enterprises Inc.
  • Taibang Biologic Group
  • Bio Products Laboratory（BPL）Ltd.
  • ADMA Biologics
  • Cangene Corporation
  • Kamada Ltd.
  • Saol Therapeutics Inc.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと潜在的な分析

第36章 付録

目次
Product Code: r18891

Hyperimmune globulins are specialized preparations of antibodies enriched with specific antibodies against a particular pathogen or antigen. These preparations are obtained from the plasma of individuals who have high levels of antibodies against a specific infectious agent or toxin. They are utilized for passive immunization to confer immediate immunity against certain diseases, particularly in situations requiring prompt protection.

The primary types of hyperimmune globulins include hepatitis B hyperimmune globulin, rabies hyperimmune globulin, tetanus hyperimmune globulin, cytomegalovirus (CMV) hyperimmune globulin, varicella-zoster virus (VZV) hyperimmune globulin, respiratory syncytial virus (RSV) hyperimmune globulin, among others. Hepatitis B hyperimmune globulin, for example, is derived from the plasma of donors with high antibody titers against the hepatitis B virus. These preparations are administered via various routes such as intramuscular or intravenous, serving diverse applications across governmental, private, and other sectors.

The hyperImmune globulin market research report is one of a series of new reports from The Business Research Company that provides hyperImmune globulin market statistics, including hyperImmune globulins industry global market size, regional shares, competitors with a hyperImmune globulin market share, detailed hyperImmune globulin market segments, market trends, and opportunities, and any further data you may need to thrive in the hyperImmune globulins industry. This hyperImmune globulin market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hyperImmune globulins market size has grown strongly in recent years. It will grow from $1.78 billion in 2023 to $1.91 billion in 2024 at a compound annual growth rate (CAGR) of 7.5%. In the historical period, growth can be attributed to enhanced government support, increased healthcare expenditures, a high prevalence of hepatitis B and rabies, heightened awareness of zoonotic diseases, and expansion of the geriatric population.

The hyperImmune globulins market size is expected to see strong growth in the next few years. It will grow to $2.57 billion in 2028 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period is expected due to the rising prevalence of infectious diseases, increasing awareness of the benefits of hyperimmune globulin injections, growing demand for immunoglobulins, rising cases of alpha-1 antitrypsin deficiency, and escalating incidence of immune deficiencies. Key trends anticipated in the forecast period include advancements and innovation in technology, substantial investment in research and development, a growing demand for passive immunity treatments, progress in plasma-derived therapies, and technological enhancements in manufacturing processes.

The hyperimmune globulin market is set to grow due to the increasing prevalence of infectious diseases. These diseases, caused by pathogens such as viruses, bacteria, fungi, and parasites, are on the rise due to factors such as antimicrobial resistance, climate change, and population growth. Hyperimmune globulins play a crucial role in combating infectious diseases by providing immediate passive immunity through concentrated antibodies targeting specific pathogens. This aids in disease prevention or treatment, as seen in cases such as chronic hepatitis B, where the number of cases in the US increased by 17% from 2021 to 2022. Therefore, the growth of infectious diseases is directly impacting the hyperimmune globulin market.

Government efforts to advance healthcare research and development are poised to boost the hyperimmune globulins market in the coming years. These initiatives are escalating due to growing demand for innovative medical solutions and the necessity to confront emerging health issues. They play a crucial role in fostering the development and accessibility of hyperimmune globulins, particularly in combating specific infectious diseases effectively. For example, in 2022, the UK government allocated £260 million (US $270.65 million) through the Business, Energy, and Industrial Strategy (BEIS) and the Department of Health and Social Care (DHSC) to enhance healthcare research and manufacturing. This funding supports NHS-led health research, new privacy-preserving platforms for diagnostics and treatment, clinical research services, and also includes £60 million (US $63.60 million) to bolster life sciences manufacturing in the UK. Therefore, the increasing government focus on healthcare research and development is a key driver of the hyperimmune globulins market.

In April 2022, Grifols S.A., a pharmaceutical company based in Spain, acquired Biotest for an undisclosed sum. This acquisition positions Grifols to enhance and diversify its product portfolio, increase the availability of plasma therapies, operate the largest private European network of plasma centers with 87 centers, and stimulate revenue growth and margin expansion. Biotest, a biotechnology company based in Germany, specializes in hyperimmune globulins, which aligns with Grifols' strategic goals.

Major companies operating in the hyperimmune globulins market are F. Hoffmann-La Roche AG, Bayer AG, Takeda Pharmaceutical Company Limited, Baxter International Inc., CSL Ltd., Fresenius Kabi AG, Grifols SA, Octapharma AG, Shanghai RAAS Blood Products Co. Ltd., Emergent BioSolutions Inc., Kedrion Biopharma Inc., LFB SA, Hualan Biological Engineering Inc., FFF Enterprises Inc., Taibang Biologic Group, Bio Products Laboratory (BPL) Ltd., ADMA Biologics, Cangene Corporation, Kamada Ltd., Saol Therapeutics Inc., Omrix Biopharmaceuticals Ltd., Shire, Sichuan Yuanda Shuyang Pharmaceutical Co. Ltd., BioCare Inc.

North America was the largest region in the hyperimmune globulins market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hyperimmune globulins market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the hyperimmune globulins market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The hyperimmune globulins market consists of sales of bayrab, hepaGam B, Tetanus Immune Globulin (TIG), variZIG, respiGam, and cytogam. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

HyperImmune Globulins Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hyperimmune globulins market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hyperimmune globulins ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The hyperimmune globulins market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Hepatitis B Hyperimmune Globulin; Rabies Hyperimmune Globulin; Tetanus Hyperimmune Globulin; Cytomegalovirus (CMV) Hyperimmune Globulin; Varicella-Zoster Virus (VZV) Hyperimmune Globulin; Respiratory Syncytial Virus (RSV) Hyperimmune Globulin; Other Types
  • 2) By Route Of Administration: Intramuscular; Intravenous
  • 3) By Application: Government Institution; Private Sector; Other Applications
  • Companies Mentioned: F. Hoffmann-La Roche AG; Bayer AG; Takeda Pharmaceutical Company Limited; Baxter International Inc.; CSL Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Hyperimmune Globulins Market Characteristics

3. Hyperimmune Globulins Market Trends And Strategies

4. Hyperimmune Globulins Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Hyperimmune Globulins Market Size and Growth

  • 5.1. Global Hyperimmune Globulins Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Hyperimmune Globulins Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Hyperimmune Globulins Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Hyperimmune Globulins Market Segmentation

  • 6.1. Global Hyperimmune Globulins Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hepatitis B Hyperimmune Globulin
  • Rabies Hyperimmune Globulin
  • Tetanus Hyperimmune Globulin
  • Cytomegalovirus (CMV) Hyperimmune Globulin
  • Varicella-Zoster Virus (VZV) Hyperimmune Globulin
  • Respiratory Syncytial Virus (RSV) Hyperimmune Globulin
  • Other Types
  • 6.2. Global Hyperimmune Globulins Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Intramuscular
  • Intravenous
  • 6.3. Global Hyperimmune Globulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Government Institution
  • Private Sector
  • Other Applications

7. Hyperimmune Globulins Market Regional And Country Analysis

  • 7.1. Global Hyperimmune Globulins Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Hyperimmune Globulins Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Hyperimmune Globulins Market

  • 8.1. Asia-Pacific Hyperimmune Globulins Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Hyperimmune Globulins Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Hyperimmune Globulins Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Hyperimmune Globulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Hyperimmune Globulins Market

  • 9.1. China Hyperimmune Globulins Market Overview
  • 9.2. China Hyperimmune Globulins Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Hyperimmune Globulins Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Hyperimmune Globulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Hyperimmune Globulins Market

  • 10.1. India Hyperimmune Globulins Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Hyperimmune Globulins Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Hyperimmune Globulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Hyperimmune Globulins Market

  • 11.1. Japan Hyperimmune Globulins Market Overview
  • 11.2. Japan Hyperimmune Globulins Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Hyperimmune Globulins Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Hyperimmune Globulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Hyperimmune Globulins Market

  • 12.1. Australia Hyperimmune Globulins Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Hyperimmune Globulins Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Hyperimmune Globulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Hyperimmune Globulins Market

  • 13.1. Indonesia Hyperimmune Globulins Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Hyperimmune Globulins Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Hyperimmune Globulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Hyperimmune Globulins Market

  • 14.1. South Korea Hyperimmune Globulins Market Overview
  • 14.2. South Korea Hyperimmune Globulins Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Hyperimmune Globulins Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Hyperimmune Globulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Hyperimmune Globulins Market

  • 15.1. Western Europe Hyperimmune Globulins Market Overview
  • 15.2. Western Europe Hyperimmune Globulins Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Hyperimmune Globulins Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Hyperimmune Globulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Hyperimmune Globulins Market

  • 16.1. UK Hyperimmune Globulins Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Hyperimmune Globulins Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Hyperimmune Globulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Hyperimmune Globulins Market

  • 17.1. Germany Hyperimmune Globulins Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Hyperimmune Globulins Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Hyperimmune Globulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Hyperimmune Globulins Market

  • 18.1. France Hyperimmune Globulins Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Hyperimmune Globulins Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Hyperimmune Globulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Hyperimmune Globulins Market

  • 19.1. Italy Hyperimmune Globulins Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Hyperimmune Globulins Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Hyperimmune Globulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Hyperimmune Globulins Market

  • 20.1. Spain Hyperimmune Globulins Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Hyperimmune Globulins Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Hyperimmune Globulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Hyperimmune Globulins Market

  • 21.1. Eastern Europe Hyperimmune Globulins Market Overview
  • 21.2. Eastern Europe Hyperimmune Globulins Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Hyperimmune Globulins Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Hyperimmune Globulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Hyperimmune Globulins Market

  • 22.1. Russia Hyperimmune Globulins Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Hyperimmune Globulins Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Hyperimmune Globulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Hyperimmune Globulins Market

  • 23.1. North America Hyperimmune Globulins Market Overview
  • 23.2. North America Hyperimmune Globulins Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Hyperimmune Globulins Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Hyperimmune Globulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Hyperimmune Globulins Market

  • 24.1. USA Hyperimmune Globulins Market Overview
  • 24.2. USA Hyperimmune Globulins Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Hyperimmune Globulins Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Hyperimmune Globulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Hyperimmune Globulins Market

  • 25.1. Canada Hyperimmune Globulins Market Overview
  • 25.2. Canada Hyperimmune Globulins Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Hyperimmune Globulins Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Hyperimmune Globulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Hyperimmune Globulins Market

  • 26.1. South America Hyperimmune Globulins Market Overview
  • 26.2. South America Hyperimmune Globulins Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Hyperimmune Globulins Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Hyperimmune Globulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Hyperimmune Globulins Market

  • 27.1. Brazil Hyperimmune Globulins Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Hyperimmune Globulins Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Hyperimmune Globulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Hyperimmune Globulins Market

  • 28.1. Middle East Hyperimmune Globulins Market Overview
  • 28.2. Middle East Hyperimmune Globulins Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Hyperimmune Globulins Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Hyperimmune Globulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Hyperimmune Globulins Market

  • 29.1. Africa Hyperimmune Globulins Market Overview
  • 29.2. Africa Hyperimmune Globulins Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Hyperimmune Globulins Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Hyperimmune Globulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Hyperimmune Globulins Market Competitive Landscape And Company Profiles

  • 30.1. Hyperimmune Globulins Market Competitive Landscape
  • 30.2. Hyperimmune Globulins Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche AG
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Bayer AG
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Takeda Pharmaceutical Company Limited
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Baxter International Inc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. CSL Ltd.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Hyperimmune Globulins Market Other Major And Innovative Companies

  • 31.1. Fresenius Kabi AG
  • 31.2. Grifols SA
  • 31.3. Octapharma AG
  • 31.4. Shanghai RAAS Blood Products Co. Ltd.
  • 31.5. Emergent BioSolutions Inc.
  • 31.6. Kedrion Biopharma Inc.
  • 31.7. LFB SA
  • 31.8. Hualan Biological Engineering Inc.
  • 31.9. FFF Enterprises Inc.
  • 31.10. Taibang Biologic Group
  • 31.11. Bio Products Laboratory (BPL) Ltd.
  • 31.12. ADMA Biologics
  • 31.13. Cangene Corporation
  • 31.14. Kamada Ltd.
  • 31.15. Saol Therapeutics Inc.

32. Global Hyperimmune Globulins Market Competitive Benchmarking

33. Global Hyperimmune Globulins Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Hyperimmune Globulins Market

35. Hyperimmune Globulins Market Future Outlook and Potential Analysis

  • 35.1 Hyperimmune Globulins Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Hyperimmune Globulins Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Hyperimmune Globulins Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer